Xerostomia
Conditions
Interventions
A total of 120 patients will be evaluated between April 2019 and April 2021. Questionnaires will be applied for anamnesis, socioeconomic, WHOOQL quality of life assessment, BDI, xerostomia follow-up a
E02.594.540:
Sponsors
Univesrsidade Estadual de Montes Claros
Hospital Dilson Godinho
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with confirmed diagnosis of Squamous Cell Carcinoma in the oral cavity or oropharynx; both sexes; treated with RT exclusively; or with RT associated with chemotherapy and or surgery; over the age of 18; who agreed to participate in the study
Exclusion criteria
Exclusion criteria: Patients who had previously undergone RT in the head and neck region; patients with previous xerostomia during inclusion; patients using drugs that could interfere with xerostomia; or patients who did not agree to participate in the research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is the reduction of xerostomia induced by radiotherapy in patients with head and neck cancer after laser therapy. To assess xerostomia the xerostomia inventory and Sialometry will be used. To determine whether there has been a reduction, patients treated with laser therapy (intervention) and without laser therapy (control) will be compared | — |
Secondary
| Measure | Time frame |
|---|---|
| As secondary outcomes, it is expected to estimate the clinical effect of using the laser on the complications arising from radiotherapy treatment, such as xerostomia and mucositis, to assess the patient's anxiety and depression, the general quality of life. Qualitatively and quantitatively assess saliva, also checking the proteins present in control and intervention patients, before and after radiotherapy and low-level laser therapy. | — |
Countries
Brazil
Contacts
Public ContactAndre Guimaraes
Outcome results
None listed